Optum AI Visibility Market Strategy Report - ED Treatment Pills

Answer Capsule

Optum holds almost no recommendation-stage visibility in the October 2026 ED Treatment Pills benchmark, recording 0.68% valid recommendation coverage against a category leader at 60.81%. The brand is present in 4.39% of qualified observations and converts almost none of that presence into a shortlist position, with a single top-three placement and no first-position recommendations. The clearest weakness is a near-total absence from recommendation-shaped answers, and the clearest opportunity is rebuilding a minimal, defensible presence in the discovery and evaluation prompts where the category is actually decided.

Who This Report Is For

This report is for Optum's brand, growth, and market strategy leads, and for any stakeholder evaluating how the brand appears in AI-generated recommendations for ED treatment options.

Report Card

Executive Summary

Optum is visible but effectively under-recommended in the October 2026 ED Treatment Pills benchmark. The brand recorded 13 mentions across 296 qualified observations, a raw mention presence rate of 4.39%, and only 2 valid recommendations, a valid recommendation coverage of 0.68%. Against a category leader at 60.81% coverage, Optum sits at the bottom of the tracked set on every recommendation metric.

The mention profile is thin and heavily neutral. Of the 13 mentions, 3 were positive and 10 were neutral, with no negative mentions recorded. That produces a net sentiment score of 0.2308, the weakest framing reading among tracked brands this month and well below the category's otherwise positive tone. A low sentiment score on a small base usually signals that a brand is being named as context or comparison rather than as a recommended option.

The strongest cluster signal is also the only cluster with data. All 296 qualified observations fell into the brand recommendation class, and Optum's entire October footprint sits inside that single cluster. The pricing and value and multi-brand comparison classes carried no qualified observations this month, so the benchmark cannot yet speak to how Optum performs on cost or head-to-head prompts.

Platform behavior is fragmented. Optum registered no presence at all on ChatGPT in October, and its only valid recommendation credit came from Perplexity, where it recorded 2 valid recommendations and 1 top-three placement. Gemini, AI Mode, and AI Overviews carried neutral mentions without recommendation credit. That pattern suggests the brand is being retrieved as a reference point in some systems but is not being selected as an answer.

The clearest gap is conversion from presence to recommendation. Optum appears in 4.39% of observations but is recommended in 0.68%, a conversion far below every other tracked brand. The clearest opportunity is narrow and specific: establish a defensible recommendation position in the discovery and evaluation prompts where the category shortlist is formed, starting with the platforms where the brand already has a foothold.

What Optum Is Winning

Optum's evidence-backed wins in October 2026 are limited, and the report states that plainly.

The brand recorded no negative mentions across 13 total mentions, which means its small footprint is not being framed unfavorably. That is a neutral-to-positive baseline rather than a strength.

Optum also registered a presence on Perplexity, where it earned its only valid recommendation credit and its only top-three placement of the month. Perplexity is a narrow but real pocket of recommendation behavior for the brand.

Beyond those two observations, the data does not support claiming a meaningful win. Optum does not lead any cluster, does not lead any platform, and does not hold a recommendation position that would be described as durable.

Where Optum Has the Clearest AI Visibility Gaps

Questions This Section Answers

• How far behind Hims and Ro is Optum on valid recommendation coverage in ED treatment pills?
• Which platforms is Optum absent from or only mentioned without any recommendation credit?
• What does Optum's 0.2308 sentiment score suggest about how its ED treatment mentions are framed?

Optum's central gap is recommendation conversion. The brand is mentioned in 4.39% of qualified observations but receives valid recommendation credit in only 0.68%. Every other tracked brand converts presence into recommendation at a higher rate, and the leaders convert at multiples of Optum's rate.

The gap is most visible against Hims, which holds 92.6% presence and 60.81% valid recommendation coverage, and against Ro, which holds 82.4% presence and 55.1% coverage. Optum is not competing in the same recommendation conversation as the category leaders. It is appearing at the edges of answers rather than inside the shortlist.

Platform absence compounds the problem. Optum recorded zero presence on ChatGPT in October, which removes the brand from one of the six tracked surface families entirely. On Gemini, AI Mode, and AI Overviews, Optum appeared only in neutral contexts without recommendation credit. That means the brand is being retrieved as background information in several systems while being excluded from the recommendation layer in all of them.

The sentiment reading reinforces the pattern. Optum's net sentiment score of 0.2308 is the lowest among tracked brands, and it sits far below the 0.7 to 0.9 range recorded by most competitors. A low score on a small mention base typically indicates that mentions are neutral references or comparison anchors rather than endorsements. The observed data suggests Optum's remaining mentions cluster in non-recommendation contexts.

Biggest Opportunity

Questions This Section Answers

• Which prompt cluster offers the most realistic path to recommendation credit for Optum?
• Why does Optum need to shift from neutral reference to named option rather than build awareness from zero?
• Which platforms give Optum the most direct route to closing the neutral-mention-to-recommendation gap?

Optum's clearest path forward is to convert its existing neutral presence into valid recommendation credit inside the discovery and evaluation cluster, which is the only cluster with qualified observations this month.

The brand already appears in that cluster, so the opportunity is not about building awareness from zero. It is about moving from being named as context to being named as an option. That requires the pages, sources, and citation footprint that AI systems retrieve when they assemble a shortlist for ED treatment questions to describe Optum in recommendation-relevant terms.

The specific target is the platform mix where Optum already has a foothold. Perplexity produced the brand's only recommendation credit in October, and Gemini, AI Mode, and AI Overviews produced neutral mentions without credit. Closing the gap between neutral mention and valid recommendation on those surfaces is the most direct route to improving the brand's position.

Competitive Landscape

Questions This Section Answers

• Where does Optum rank on top-three and rank-one rates against Hims, Ro, and GoodRx Care?
• How should Optum's average recommended rank of 2.00 be interpreted given its single top-three placement?
• Which competitor sentiment scores sit closest to Optum's 0.2308, and how wide is the gap?

Hims and Ro hold the strongest recommendation-stage positions in the ED Treatment Pills category, with GoodRx Care close behind on placement strength. Optum sits at the bottom of the tracked set on every recommendation metric.

Average recommended rank covers rank-eligible recommendations only.

Optum's single top-three placement gives it a 0.34% top-three rate, the lowest in the tracked set, and the brand recorded no first-position recommendations at all. Its average recommended rank of 2.00 reflects that one placement rather than a stable position, so it should be read as a small-sample figure. The sentiment column is where Optum separates most sharply from the rest of the category, sitting more than 0.4 points below the next lowest brand.

Prompt Evidence

Questions This Section Answers

• Which specific prompts produced Optum's only valid recommendation and top-three placement?
• On which ED treatment prompts did Optum appear as a neutral reference while competitors held the shortlist?

Perplexity / Brand Recommendation Prompt: "What generic Viagra is best?" Result: Optum received one of its two valid recommendations and its only top-three placement of the month, appearing as a secondary option behind the category leaders.

Gemini / Brand Recommendation Prompt: "ed meds online" Result: Optum appeared in a neutral context without recommendation credit, consistent with the brand being retrieved as a reference point rather than a recommended provider.

AI Mode / Brand Recommendation Prompt: "where to buy viagra" Result: Optum was mentioned without entering the shortlist, while Hims, Ro, and GoodRx Care carried the recommendation positions.

ChatGPT / Brand Recommendation Prompt: "telehealth companies" Result: Optum did not appear at all, reflecting the brand's zero presence on ChatGPT in October 2026.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map every prompt where Optum appears, where it is recommended, and where it is absent, with platform-level detail across all six tracked surface families.

Phase 2: Recommendation Readiness Plan Identify the specific discovery and evaluation prompts where Optum can realistically enter the shortlist, and define the evidence and framing required to support that position.

Phase 3: Owned Answer Layer Buildout Strengthen the Optum pages that AI systems retrieve for ED treatment questions so they describe the brand in recommendation-relevant terms rather than neutral reference terms.

Phase 4: Citation / Authority Layer Development Build the source footprint that AI systems draw on when assembling ED treatment shortlists, focusing on the health publisher and comparison contexts where Optum currently appears without credit.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Optum's presence, valid recommendation coverage, top-three rate, and sentiment month over month to confirm whether neutral mentions are converting into recommendation credit.

Why This Matters

Questions This Section Answers

• What happens commercially when a brand is retrievable in AI answers but not recommendable?
• Why is the gap between Optum's 4.39% presence and 0.68% recommendation coverage the central commercial issue?

AI systems are now forming the buyer shortlist for ED treatment options before a user ever visits a brand page. Optum's October 2026 position shows what happens when a brand is retrievable but not recommendable: it appears in answers as context, it carries a weak framing signal, and it is excluded from the shortlist that actually drives consideration.

Presence alone is not enough. The benchmark shows that Optum is mentioned in 4.39% of qualified observations while being recommended in 0.68%, and that gap is the entire commercial story. Closing it requires targeted work on the prompt layer, the page layer, and the citation layer that AI systems use to decide which brands belong in the answer.

Core Metrics

Sentiment Score

Questions This Section Answers

• How is Optum's net sentiment score calculated from its positive, neutral, and negative mentions?
• Why does a high mention count mislead when most mentions are neutral references rather than recommendations?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Optum in October 2026, that is (3 × 1 + 10 × 0 + 0 × -1) / 13, which produces a score of 0.2308.

This matters because unclassified mention counts are misleading. A brand with 13 mentions sounds more visible than it is when 10 of those mentions are neutral references rather than recommendations. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement.

Optum's score is the lowest among tracked brands in October 2026, and it sits far below the 0.7 to 0.9 range recorded by most competitors. Classified sentiment is required before interpreting AI visibility, and in Optum's case the classification shows that the brand's small footprint is mostly neutral context rather than recommendation support.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Optum's AI recommendation visibility in the ED Treatment Pills category. It is not a client result and does not describe work performed by CiteWorks Studio.
2. The reporting month is October 2026, drawn from the LLM Authority Index AI Market Discovery Index for ED Treatment Pills.
3. Six AI/search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode. All six registered observations in October 2026.
4. The October run began with 800 prompt-surface observations and 658 unique questions. Of those, 547 were relevant, 253 were irrelevant, and 296 qualified for the public benchmark.
5. Brand-level percentages use the 296 qualified observations as the public denominator, not the raw collection.
6. The tracked competitor universe contains 10 brands: Hims, Ro, GoodRx Care, Lemonaid Health, plushcare, BlueChew, Rex MD, Blink Health, K Health, and Optum.
7. Three public high-intent clusters were defined for this benchmark. Only the brand recommendation cluster carried qualified observations in October 2026. The pricing and value and multi-brand comparison clusters carried no qualified observations.
8. A mention is counted when Optum appears in a qualified observation at all, regardless of recommendation status. A valid recommendation is counted only when the dataset marks Optum as a recommended option, not when it appears as a neutral reference, comparison anchor, or cautionary mention.
9. Top-three rate and rank-one rate are calculated against the 296 qualified observations. Average recommended rank covers rank-eligible recommendations only.
10. Optum's October base is small. With 13 mentions, 2 valid recommendations, and 1 top-three placement, individual placements carry outsized weight, and percentage movements should be read with that caveat.
11. The benchmark records change and position. It does not establish why a change occurred, and source presence in AI responses is not treated as proof of causation. Platform-level sentiment values rest on very small mention counts and are directional only.
12. The public benchmark does not measure market share, revenue attribution, organic search ranking performance, or social media sentiment.

See How AI Is Recommending Your Brand

The public benchmark shows where Optum stands in AI-generated recommendations for ED treatment options. A company-level AI visibility audit goes deeper, mapping the specific prompts, platforms, competitors, and evidence sources that shape whether Optum enters the shortlist or stays on the sidelines.